Hydroxyurea in the Treatment of Sickle Cell Disease
NCT02709681
·
clinicaltrials.gov ↗
COMPLETED
Status
628
Enrollment
OTHER
Sponsor class
Conditions
Sickle Cell Disease
Interventions
OTHER:
Physician standard-of-care in SCD patients
Sponsor
Società Italiana Talassemie ed Emoglobinopatie